HIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with ...

Efavirenz is an important drug for treating HIV infection, but it causes negative neuropsychiatric effects in roughly 50% of ...

It could be a real breakthrough for people at risk for HIV infection: A shot given every 6 months that reduces their risk by a whopping 96%.

Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...

Ending Acquired Immune Deficiency Syndrome (AIDS) as a public health threat here by 2030 will take much effort as it will all around the world. The key, ...

It was a busy week for the biotech sector with a lot of important data readouts at the European Society for Medical Oncology ...

The use of Pre-exposure Prophylasix (PrEP) has expanded significantly over the past few years contributing to reduction of new HIV infections.

Dolutegravir is an HIV integrase ... with few treatment discontinuations due to adverse effects. Headache, nausea and diarrhea were the most likely side effects reported in clinical trials.